Glutamate Signaling and Drug Abuse

谷氨酸信号传导和药物滥用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The abuse of the amphetamine-like psychostimulants is a medical and social problem throughout the world. The rewarding properties of these drugs are linked to their capacity to increase extracellular concentration of dopamine in the forebrain, notably in the nucleus accumbens. The dopaminergic neurons that innervate nucleus accumbens originate in the ventral tegmental area which has been shown to play a critical role in development of chronic drug effects. Despite the advances in our understanding of cellular and molecular actions of these drugs, effective pharmacological treatments for amphetamine and cocaine addiction remain elusive. More recently, a number of investigations have shown that in addition to dopaminergic role in psychostimulant effects, excitatory neurotransmission also plays a very critical role. Glutamate is the major excitatory neurotransmitter in the brain and both nucleus accumbens and ventral tegmental area receive a major glutamatergic innervation from prefrontal cortex. These studies suggest that drugs acting on excitatory neurotransmission may be effective therapeutic agents for treating psychostimulant abuse. The data presented in this proposal suggest that the recently discovered proteins that bind to glutamate receptors can alter glutamatergic transmission and may play an important role in long lasting neuroadaptations after repeated drug exposure. The Homer family of proteins is one of the glutamate receptor binding proteins that bind specifically to metabotropic glutamate receptors. The expression of these proteins in nucleus accumbens is altered after repeated cocaine exposure. Moreover, reducing the level of these proteins in NA during repeated exposure to cocaine prevents the development of behavioral sensitization. Based on these results and others in literature a series of experiments are proposed to study the functional role of these scaffolding proteins in excitatory transmission in nucleus accumbens and their role in drug induced synaptic plasticity.
描述(由申请人提供):苯丙胺类药物的滥用

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glutamatergic plasticity in medial prefrontal cortex and ventral tegmental area following extended-access cocaine self-administration.
  • DOI:
    10.1016/j.brainres.2011.06.041
  • 发表时间:
    2011-09-21
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Ghasemzadeh MB;Vasudevan P;Giles C;Purgianto A;Seubert C;Mantsch JR
  • 通讯作者:
    Mantsch JR
Neuroadaptations in the cellular and postsynaptic group 1 metabotropic glutamate receptor mGluR5 and Homer proteins following extinction of cocaine self-administration.
  • DOI:
    10.1016/j.neulet.2008.12.028
  • 发表时间:
    2009-03-13
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Ghasemzadeh MB;Vasudevan P;Mueller C;Seubert C;Mantsch JR
  • 通讯作者:
    Mantsch JR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MOHAMMADHOSSEIN BEHNAM GHASEMZADEH其他文献

MOHAMMADHOSSEIN BEHNAM GHASEMZADEH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MOHAMMADHOSSEIN BEHNAM GHASEMZADEH', 18)}}的其他基金

KNCQ Potassium Channels and Schizophrenia
KNCQ 钾通道和精神分裂症
  • 批准号:
    8925922
  • 财政年份:
    2014
  • 资助金额:
    $ 20.62万
  • 项目类别:
KNCQ Potassium Channels and Schizophrenia
KNCQ 钾通道和精神分裂症
  • 批准号:
    8824412
  • 财政年份:
    2014
  • 资助金额:
    $ 20.62万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    6687845
  • 财政年份:
    2002
  • 资助金额:
    $ 20.62万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    6868951
  • 财政年份:
    2002
  • 资助金额:
    $ 20.62万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    6624092
  • 财政年份:
    2002
  • 资助金额:
    $ 20.62万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    7022914
  • 财政年份:
    2002
  • 资助金额:
    $ 20.62万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    6472328
  • 财政年份:
    2002
  • 资助金额:
    $ 20.62万
  • 项目类别:
GLUTAMATE RECEPTOR AND CHRONIC COCAINE
谷氨酸受体和慢性可卡因
  • 批准号:
    6129490
  • 财政年份:
    1999
  • 资助金额:
    $ 20.62万
  • 项目类别:
GLUTAMATE RECEPTOR AND CHRONIC COCAINE
谷氨酸受体和慢性可卡因
  • 批准号:
    6174713
  • 财政年份:
    1999
  • 资助金额:
    $ 20.62万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了